These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34329607)

  • 1. Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Anger HA; Raymond EG; Grant M; Haskell S; Boraas C; Tocce K; Banks J; Coplon L; Shochet T; Platais I; Winikoff B
    Contraception; 2021 Dec; 104(6):659-665. PubMed ID: 34329607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
    Anger HA; Raymond EG
    Contraception; 2023 Aug; 124():110055. PubMed ID: 37088124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and service delivery outcomes following medication abortion provided with or without pretreatment ultrasound or pelvic examination: An updated comparative analysis.
    Anger HA; Raymond EG
    Contraception; 2024 Jul; ():110552. PubMed ID: 39059683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
    Upadhyay UD; Raymond EG; Koenig LR; Coplon L; Gold M; Kaneshiro B; Boraas CM; Winikoff B
    JAMA Intern Med; 2022 May; 182(5):482-491. PubMed ID: 35311911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
    Chong E; Shochet T; Raymond E; Platais I; Anger HA; Raidoo S; Soon R; Grant MS; Haskell S; Tocce K; Baldwin MK; Boraas CM; Bednarek PH; Banks J; Coplon L; Thompson F; Priegue E; Winikoff B
    Contraception; 2021 Jul; 104(1):43-48. PubMed ID: 33781762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
    Raymond E; Chong E; Winikoff B; Platais I; Mary M; Lotarevich T; Castillo PW; Kaneshiro B; Tschann M; Fontanilla T; Baldwin M; Schnyer A; Coplon L; Mathieu N; Bednarek P; Keady M; Priegue E
    Contraception; 2019 Sep; 100(3):173-177. PubMed ID: 31170384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
    Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care.
    Kerestes C; Delafield R; Elia J; Chong E; Kaneshiro B; Soon R
    Contraception; 2021 Jul; 104(1):67-72. PubMed ID: 33933421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified medical abortion screening: a demonstration project.
    Raymond EG; Tan YL; Comendant R; Sagaidac I; Hodorogea S; Grant M; Sanhueza P; Van Pratt E; Gillespie G; Boraas C; Weaver MA; Platais I; Bousieguez M; Winikoff B
    Contraception; 2018 Apr; 97(4):292-296. PubMed ID: 29170088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Person-centered, high-quality care from a distance: A qualitative study of patient experiences of TelAbortion, a model for direct-to-patient medication abortion by mail in the United States.
    Kerestes C; Delafield R; Elia J; Shochet T; Kaneshiro B; Soon R
    Perspect Sex Reprod Health; 2022 Dec; 54(4):177-187. PubMed ID: 36229416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "False positive" urine pregnancy test results after successful medication abortion.
    Raymond EG; Anger HA; Chong E; Haskell S; Grant M; Boraas C; Tocce K; Banks J; Kaneshiro B; Baldwin MK; Coplon L; Bednarek P; Shochet T; Platais I
    Contraception; 2021 Jun; 103(6):400-403. PubMed ID: 33596414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States.
    Rosenberg JD; Raymond E; Shochet T
    Contraception; 2023 Jun; 122():109996. PubMed ID: 36841460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
    Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Hannum C; Ho S; Schwarz EB; Gold M
    Contraception; 2022 Mar; 107():36-41. PubMed ID: 34555420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of telehealth medication abortion in the USA.
    Upadhyay UD; Koenig LR; Meckstroth K; Ko J; Valladares ES; Biggs MA
    Nat Med; 2024 Apr; 30(4):1191-1198. PubMed ID: 38361123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote Reproductive Rights.
    Rebouché R
    Am J Law Med; 2022 Jul; 48(2-3):244-255. PubMed ID: 36715252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miles and days until medical abortion via TelAbortion versus clinic in Oregon and Washington, USA.
    Beardsworth KM; Doshi U; Raymond E; Baldwin MK
    BMJ Sex Reprod Health; 2022 Jan; 48(e1):e38-e43. PubMed ID: 33789954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.
    Aiken A; Lohr PA; Lord J; Ghosh N; Starling J
    BJOG; 2021 Aug; 128(9):1464-1474. PubMed ID: 33605016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication Abortion Provided Through Telemedicine in Four U.S. States.
    Kohn JE; Snow JL; Simons HR; Seymour JW; Thompson TA; Grossman D
    Obstet Gynecol; 2019 Aug; 134(2):343-350. PubMed ID: 31306317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic.
    Mello K; Smith MH; Hill BJ; Chakraborty P; Rivlin K; Bessett D; Norris AH; McGowan ML
    Contraception; 2021 Jul; 104(1):111-116. PubMed ID: 33930382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
    Whitehouse KC; Shochet T; Lohr PA
    Contraception; 2022 Jun; 110():21-26. PubMed ID: 35259410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.